Request Deal Involvement

Forbion led a $170m Series B round in Beacon Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

JP Morgan

financial advisors

JP Morgan

Edelman

pr advisors

Edelman

FTI Consulting

pr advisors

FTI Consulting

or

Principals

BEACON THERAPEUTICS

target

BEACON THERAPEUTICS

SYNCONA LTD

bidder

SYNCONA LTD

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

ADVENT LIFE SCIENCES

bidder

ADVENT LIFE SCIENCES

OXFORD SCIENCE ENTERPRISES

bidder

OXFORD SCIENCE ENTERPRISES

TCG CROSSOVER

bidder

TCG CROSSOVER

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Forbion led a $170m Series B round in Beacon Therapeutics.